GlaxoSmithKline | Capitale Ordinario

Prezzo Delle Azioni
2,187.50
Cambio Giornaliero
7.50 0.34%
Mensile
15.04%
Annuale
51.59%
Q1 Previsione
1,839.16




Capitale Ordinario Cambiamento Data
AbbVie USD 1.77B 1.75B 2025-06
Alcon AG USD 494.6M 0 2025-09
Almirall EUR 214.79M 154.21 2025-06
Amgen USD 538M 300K 2025-09
AstraZeneca USD 1.55B 1.16B 2025-09
Bayer EUR 982.42M 0 2025-09
Biogen USD 146.7M 200K 2025-09
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Eli Lilly USD 946.83M 354.23M 2025-06
Fresenius EUR 563.24M 0 2025-09
Fresenius Medical Care EUR 289.85M 3.56M 2025-09
Galapagos EUR 65.9M 0 2025-09
Genmab DKK 10M 56M 2025-03
Gilead Sciences USD 1.24B 0 2025-09
GlaxoSmithKline GBP 4.08B 49.43M 2025-12
Glaxosmithkline GBP 4.03B 2.68B 2025-09
GRIFOLS EUR 679.73M 0 2025-09
Hikma Pharmaceutical USD 40M 0 2024-12
Lonza CHF 72M 0 2024-12
Merck EUR 434.78M 130.22M 2025-06
Merck USD 2.49B 15.79M 2025-09
Novartis USD 1.94B 23.4M 2025-06
Novo Nordisk DKK 4.44B 0 2025-12
Orion EUR 140.69M 48.49M 2025-06
Pfizer USD 5.69B 1000K 2025-09
Philips EUR 950.98M 405K 2025-09
Recordati EUR 205.83M 270K 2025-09
Regeneron Pharmaceuticals USD 105.3M 1.1M 2025-09
Roche Holding CHF 795.62M 699.54K 2025-12
Smith & Nephew USD 875.96M 1.61M 2025-12
UCB EUR 584M 0 2024-12


GlaxoSmithKline Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.